ABSI

Absci Corp ABSI

NasdaqSmall CapHealthcare

13F Pro quality score

Rank #2,905 of 2,925

Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.

Revenue

$318.0K

Quarter to Jun 30

Net income

$-33.21M

Quarter to Jun 30

Free cash flow

$-27.57M

Quarter to Jun 30

Top Institutional Holders

as of Q2 2026
$1.75B total
Reading the latest SEC filing…

Key Metrics

Revenue

Q2 2026
EDGAR

Net Income

Q2 2026
EDGAR

EPS (Diluted)

Q2 2026
EDGAR

ROIC

Q2 2026
EDGAR

Free Cash Flow

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/ABSI

Earnings Per Share

13fpro.ai/company/ABSI

Loading ratio trend…

ABSI key financials by period

Reported revenue, net income and operating margin by fiscal year, from Absci Corp's annual filings on SEC EDGAR.

Absci Corp reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2025$2.8M$-115.2M—
FY 2024$4.5M$-103.1M—
FY 2023$5.7M$-110.6M—
FY 2022$5.7M$-104.9M—
FY 2021$4.8M$-101.0M—
FY 2020$4.8M$-14.4M—
Source: ABSI filings on SEC EDGAR →

Ranked by quality-factor profile and overlapping institutional ownership, from the latest 13F filings and SEC financials.

ABSI insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About Absci Corp (ABSI): stock profile, AI score and financials

Absci Corp (ABSI) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores ABSI at 7.4/100 on a composite quality score built from its SEC filings, placing it at rank #2,905 of 2,925 stocks — the bottom half of the AI-ranked universe. ABSI scores in the top quartile across institutional flow (92.6). Areas of concern include free cash flow (0.6) and revenue scale (0.7), which score below median versus the broader universe. Shareholder dilution risk is elevated at 1.1/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), Absci Corp reports quarterly revenue of $318.0K, net income of $-33.2M, free cash flow of $-27.6M. Top institutional holders of ABSI by reported 13-F value include FMR, ARK Investment Management, BlackRock, based on the most recent SEC filings. ABSI trades on the Nasdaq exchange and files with the SEC under CIK 1672688. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ABSI daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Absci Corp directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1672688 →